|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0006610,
umls-concept:C0030705,
umls-concept:C0032207,
umls-concept:C0144576,
umls-concept:C0243161,
umls-concept:C0332293,
umls-concept:C0677886,
umls-concept:C0871261,
umls-concept:C1442989,
umls-concept:C1704632,
umls-concept:C1706817,
umls-concept:C1707455,
umls-concept:C2347296,
umls-concept:C2911692
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
1999-4-1
|
|
pubmed:abstractText |
To assess CA-125 as a measure of response in patients treated with paclitaxel.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
17
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
501-8
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:10080591-Antineoplastic Agents,
pubmed-meshheading:10080591-Antineoplastic Agents, Phytogenic,
pubmed-meshheading:10080591-CA-125 Antigen,
pubmed-meshheading:10080591-Disease-Free Survival,
pubmed-meshheading:10080591-Epithelium,
pubmed-meshheading:10080591-False Negative Reactions,
pubmed-meshheading:10080591-False Positive Reactions,
pubmed-meshheading:10080591-Female,
pubmed-meshheading:10080591-Humans,
pubmed-meshheading:10080591-Organoplatinum Compounds,
pubmed-meshheading:10080591-Ovarian Neoplasms,
pubmed-meshheading:10080591-Paclitaxel
|
|
pubmed:year |
1999
|
|
pubmed:articleTitle |
Comparison of standard and CA-125 response criteria in patients with epithelial ovarian cancer treated with platinum or paclitaxel.
|
|
pubmed:affiliation |
Mount Vernon Centre for Cancer Treatment, Middlesex, United Kingdom.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Multicenter Study
|
